HTRA1 promotes EMT through the HDAC6 /Ac‐α‐tubulin pathway in human GBM cells
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14605 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Wenbo Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Qilu Hospital, Shandong University, Jinan,…. Hauptthemen laut MEDLINE: Glioma, Tubulin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Research Center of Shandong University, Research Project of Jinan Microecological Biomedicine Shandong Laboratory, Department of Science and Technology of Shandong Province.
Abstract (Originalsprache)
Background
The infiltrative nature of human gliomas renders complete surgical removal of tumors futile. Thus, illuminating mechanisms of their infiltrative properties may improve therapies and outcomes of glioma patients.
Methods
Comprehensive bioinformatic analyses of PRSS family were undertaken. Transfection of HTRA1 siRNAs was used to suppress HTRA1 expression. CCK‐8, EdU, and colony formation assay were employed to assess cell viability, and cell migration/invasion was detected by transwell, wound healing, and 3D tumor spheroid invasion assays. Immunoprecipitation was applied to study the mechanism that HTRA1 affected cell migration. In addition, in situ xenograft tumor model was employed to explore the role of HTRA1 in glioma growth in vivo.
Results
HTRA1 knockdown could lead to suppression of cell viability, migration and invasion, as well as increased apoptosis. Immunoprecipitation results indicates HTRA1 might facilitate combination between HDAC6 and α‐tubulin to enhance cell migration by decreasing α‐tubulin acetylation. Besides, HTRA1 knockdown inhibited the growth of xenografts derived from orthotopic implantation of GBM cells and prolonged the survival time of tumor‐bearing mice.
Conclusion
Our results indicate that HTRA1 promotes the proliferation and migration of GBM cells in vitro and in vivo, and thus may be a potential target for treatment in gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Qilu Hospital, Shandong University, Jinan, China.
- Jinan Microecological Biomedicine Shandong Laboratory and Shandong Key Laboratory of Brain Function Remodeling, Jinan, China.
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China.
- Department of Biomedicine, University of Bergen, Bergen, Norway.
ORCID-Profile: Mingzhi Han, Xingang Li, Bin Huang
Förderung
- Clinical Research Center of Shandong University
- Research Project of Jinan Microecological Biomedicine Shandong Laboratory
- Department of Science and Technology of Shandong Province
- Special Foundation for Taishan Scholars
- Shandong Provincial Laboratory Project
Zitieren
APA
Zhao, W., Wu, Y., Wang, S., Zhao, F., Liu, W., Xue, Z., Zhang, L., Wang, J., Han, M., Li, X., & Huang, B. (2024). HTRA1 promotes EMT through the HDAC6 /Ac‐α‐tubulin pathway in human GBM cells. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14605
Vancouver
Zhao W, Wu Y, Wang S, Zhao F, Liu W, Xue Z, et al. HTRA1 promotes EMT through the HDAC6 /Ac‐α‐tubulin pathway in human GBM cells. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14605
BibTeX
@article{Zhao2024,
author = {Zhao, Wenbo and Wu, Yibo and Wang, Shuai and Zhao, Feihu and Liu, Wenyu and Xue, Zhiyi and Zhang, Lin and Wang, Jian and Han, Mingzhi and Li, Xingang and Huang, Bin},
title = {HTRA1 promotes EMT through the HDAC6 /Ac‐α‐tubulin pathway in human GBM cells},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14605}
}
EUVIMED